Cargando…

Noninvasive Diagnosis of Hepatic Steatosis Using Fat Attenuation Parameter Measured by FibroTouch and a New Algorithm in CHB Patients

BACKGROUND: Chronic hepatitis B (CHB) remains a major public health problem worldwide, and the prevalence of CHB patients with hepatic steatosis is gradually increasing. Noninvasive approaches for the assessment of hepatic steatosis have been developed as alternatives to liver biopsy. OBJECTIVES: Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Hong, Wang, Chun-Ling, Lai, Jing, Yu, Su-Lin, Xie, Dong-Ying, Gao, Zhi-Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088638/ https://www.ncbi.nlm.nih.gov/pubmed/27822268 http://dx.doi.org/10.5812/hepatmon.40263

Ejemplares similares

Diagnostic Performance of FibroTouch Ultrasound Attenuation Parameter and Liver Stiffness Measurement in Assessing Hepatic Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
por: Qu, Ying, et al.
Publicado: (2021)

Attenuation parameter and liver stiffness measurement using FibroTouch vs Fibroscan in patients with chronic liver disease
por: Ng, Ying Zhuang, et al.
Publicado: (2021)

Prospective Comparison of Transient Elastography Using Two Different Devices: Performance of FibroScan and FibroTouch
por: Serra, Joao Tiago, et al.
Publicado: (2020)

Analysis of clinical features and identification of risk factors in patients with non-alcoholic fatty liver disease based on FibroTouch
por: Liao, Yan, et al.
Publicado: (2023)

Diagnostic of FibroTouch and six serological models in assessing the degree of liver fibrosis among patients with chronic hepatic disease: A single-center retrospective study
por: Zuo, Zhongbao, et al.
Publicado: (2022)

Reproducibility of ultrasound-guided attenuation parameter (UGAP) to the noninvasive evaluation of hepatic steatosis
por: Zhao, Yanan, et al.
Publicado: (2022)

Comparing the controlled attenuation parameter using FibroScan and attenuation imaging with ultrasound as a novel measurement for liver steatosis
por: Hsu, Po-Ke, et al.
Publicado: (2021)

Reproducibility of ultrasound attenuation imaging for the noninvasive evaluation of hepatic steatosis
por: Yoo, Jeongin, et al.
Publicado: (2020)

Noninvasive assessment of paediatric hepatic steatosis by using attenuation imaging
por: Hwang, Sook Min, et al.
Publicado: (2023)

Retraction: Comparing the controlled attenuation parameter using FibroScan and attenuation imaging with ultrasound as a novel measurement for liver steatosis
Publicado: (2022)

Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
por: Ferraioli, Giovanna, et al.
Publicado: (2017)

FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B
por: Zeremski, Marija, et al.
Publicado: (2014)

Accuracy of attenuation imaging in the assessment of pediatric hepatic steatosis: correlation with the controlled attenuation parameter
por: Kim, Pyeong Hwa, et al.
Publicado: (2022)

Fructus Xanthii Attenuates Hepatic Steatosis in Rats Fed on High-Fat Diet
por: Li, Xiumin, et al.
Publicado: (2013)

Clinical relevance of lipid panel and aminotransferases in the context of hepatic steatosis and fibrosis as measured by transient elastography (FibroScan®)
por: Chi-Cervera, Luis Alberto, et al.
Publicado: (2021)

The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter
por: Lee, Hye Won, et al.
Publicado: (2017)

Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors
por: Broering, Dieter, et al.
Publicado: (2021)

(Pro)Renin Receptor Antagonism Attenuates High-Fat-Diet–Induced Hepatic Steatosis
por: Gayban, Ariana Julia B., et al.
Publicado: (2023)

A prospective comparative assessment of the accuracy of the FibroScan in evaluating liver steatosis
por: Jun, Baek Gyu, et al.
Publicado: (2017)

Controlled attenuation parameter measured using transient elastography for the noninvasive assessment of macrovesicular steatosis in potential living liver donors
por: Lee, Sunyoung, et al.
Publicado: (2022)

Eradication of hepatitis C virus is associated with the attenuation of steatosis as evaluated using a controlled attenuation parameter
por: Shimizu, Kohei, et al.
Publicado: (2018)

Relationship between controlled attenuated parameter and magnetic resonance imaging–proton density fat fraction for evaluating hepatic steatosis in patients with NAFLD
por: An, Ziming, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease: Noninvasive Methods of Diagnosing Hepatic Steatosis
por: AlShaalan, Rasha, et al.
Publicado: (2015)

Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods
por: Kim, Jong Man, et al.
Publicado: (2016)

Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases
por: Ni, Xi-Xi, et al.
Publicado: (2021)

The Prevalence and Determinants of Hepatic Steatosis Assessed by Controlled Attenuation Parameter in Thai Chronic Hepatitis C Patients
por: Sirinawasatien, A., et al.
Publicado: (2020)

Validation of Controlled Attenuation Parameter Measured by FibroScan as a Novel Surrogate Marker for the Evaluation of Metabolic Derangement
por: Huang, Zhimin, et al.
Publicado: (2022)

The discriminatory ability of FibroScan liver stiffness measurement, controlled attenuation parameter, and FibroScan–aspartate aminotransferase to predict severity of liver disease in children
por: Chaidez, Alexander, et al.
Publicado: (2022)

Mentha canadensis attenuates adiposity and hepatic steatosis in high-fat diet-induced obese mice
por: Han, Youngji, et al.
Publicado: (2023)

Comparison of hepatic steatosis index as noninvasive diagnostic tool and liver ultrasound for non-alcoholic steatosis in the adult population
por: Khani, Vahid, et al.
Publicado: (2022)

The clinical utility of FibroScan(®) as a noninvasive diagnostic test for liver disease
por: Wilder, Julius, et al.
Publicado: (2014)

Accuracy of controlled attenuation parameter compared with ultrasound for detecting hepatic steatosis in children with severe obesity
por: Runge, Jurgen H., et al.
Publicado: (2020)

Metabolic Stress Index Including Mitochondrial Biomarker for Noninvasive Diagnosis of Hepatic Steatosis
por: Chang, Jae Seung, et al.
Publicado: (2022)

A noninvasive diagnostic model to assess nonalcoholic hepatic steatosis in patients with chronic hepatitis B
por: Ou, Hongjie, et al.
Publicado: (2016)

Gwen Douglas, MB ChB, FRCPsych
por: Shoenberg, Peter
Publicado: (2022)

Aspirin, chronic hepatitis B (CHB) and hepatocellular carcinoma (HCC)—will there ever be enough data?
por: Crane, Harry, et al.
Publicado: (2023)

Sasa borealis Stem Extract Attenuates Hepatic Steatosis in High-Fat Diet-induced Obese Rats
por: Song, Yuno, et al.
Publicado: (2014)

Artemisia annua Leaf Extract Attenuates Hepatic Steatosis and Inflammation in High-Fat Diet-Fed Mice
por: Kim, Kyung Eun, et al.
Publicado: (2016)

Oxygenated Water Inhibits Adipogenesis and Attenuates Hepatic Steatosis in High-Fat Diet-Induced Obese Mice
por: Cheng, Yuh-Jen, et al.
Publicado: (2020)

Pathological changes of liver one year later in CHB patients with negative HBV DNA
por: Shanshan, Wu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6mpmfc3jkkn0jee9fg4hoce8eu